When: Price at or below $60.50 (just below 50 SMA)

Then: Non-negotiable structural stop exit

When: Price below $58.28 (200 SMA)

Then: Complete exit of remainder position

When: Q3 2026 earnings print (late October)

Then: Full thesis re-evaluation

HOLD with hard stop at $60.50 and 3-4% book cap; wait for MACD confirmation and margin recovery in Q3/Q4 data before adding

• Operating margin has declined from 18.3% (2024) to 9.4% (2025) to 8.5% in Q1 2026—not a recovered or guaranteed recovery
• MACD histogram is negative and expanding at -0.19; MACD line declined 50% from 0.85 to 0.42 in under 10 sessions
• ATR compressed to 1.31 from 1.80; RSI neutral at 47.45 with no bullish divergence
• Working capital deteriorated from negative $6.6 billion (2022) to negative $10.8 billion (Q1 2026)
• Current ratio at 0.54; tangible book value negative $18 billion; goodwill/intangibles at 62% of total assets
• FCF 2025 was $3.24 billion but capital returns were $4.87 billion—a $1.6 billion gap funded by $2.1 billion net debt issuance
• Interest expense rose to $599 million (2025) from $428 million (2022), making dividend growth partially debt-funded
• Total shareholder yield of 6.1% is partly debt-funded at higher interest rates, not purely cash generation
• Forward EPS consensus of $3.36 is not a fact—it is a consensus opinion with documented slow revision history
• 88% no-cut probability means multiples are priced to stay range-bound, contradicting multiple expansion arguments
• CEO 10b5-1 plan was structured to sell above current price, indicating prudent cash management rather than conviction
• Grenade, Oreo innovation, and NFL deal are positive but not material catalysts for a $79 billion market cap company

→ vs aggressive: Forward EPS of $3.36 is a consensus forecast, not a delivered fact—cocoa volatility creates double risk of simultaneous earnings cuts and multiple compression

→ vs aggressive: MACD confirmation is not excessive caution; removing it and adding on price alone increases expected loss from failed breakouts by 2-3x compared to losing 2% upside on a confirmed breakout

→ vs aggressive: The 6.1% total shareholder yield is partially debt-funded at higher interest rates, not purely cash generation; dividend growth path ends in either payout cut or further balance sheet deterioration

→ vs aggressive: The 200 SMA is not a floor—breakdown targets prior swing low at $58.30 and November 2025 lows near $51.20, with maximum drawdown exceeding 6% in bear scenarios

→ vs aggressive: Beta of 0.40 protects against market beta only, not company-specific risks from cocoa spikes, Europe weakness, or FX moves

→ vs aggressive: 88% no-cut probability contradicts multiple expansion arguments—if the bull case requires rerating and macro is priced to prevent it, the two arguments cancel each other out

→ vs aggressive: CEO 10b5-1 plan selling above current price is not a bullish tell; it is rational behavior indicating asymmetric risk perception, not conviction of higher prices

HOLD with refined tactical add triggers; no change to position size or stop

• HOLD rating is correct; trade is well-structured with stop at $60.50 and position sizing at 3 to 4 percent of book
• Forward EPS consensus of $3.36 is priced into the multiple; recovery is not yet confirmed
• Q1 2026 operating margins at 8.5% show the third year of cocoa cost shock without meaningful margin expansion
• Working capital deterioration from negative $6.6 billion to negative $10.8 billion over four years is structural, not acute stress
• Net debt to operating cash flow at 4.3x and interest coverage at 8.3x are elevated but manageable; debt-funded buybacks are a watch item, not an action item
• Cocoa price normalization can run 6 to 24 months; trade does not require timing accuracy, only positioning and patience
• Asymmetric risk-reward favors holding with disciplined adds on confirmation rather than aggressive entry
• MACD histogram at negative 0.19 with deteriorating momentum has not yet stabilized
• 88 percent no-cut probability and 8 percent recession probability create neutral macro background with positive skew
• Target prices of $68 to $70 in recovery scenario represent meaningful upside from current levels

→ vs aggressive: Framing cocoa recovery as arbitrage overstates the certainty; it is a well-informed bet, not a defined edge, because recovery has not yet materialized

→ vs aggressive: Technical pullback to 50 SMA with volatility compression is not automatically bullish; coiled MACD springs release in both directions and deteriorating momentum requires confirmation before adding

→ vs aggressive: 10b5-1 strike price does not imply bullish expectations; it merely reflects when the plan was set up and is essentially noise without non-public context

→ vs conservative: Working capital below 1.0 is the structural business model for large CPG companies, not a fragility; $800 million inventory build on $38 billion revenue is noise, not a red flag

→ vs conservative: Debt-funded buybacks of $2.1 billion in 2025 are not abnormal in a cyclical margin trough; net debt to operating cash flow at 4.3x is elevated but not crisis-level

→ vs conservative: Strategic catalysts like Grenade launch and Oreo innovation cadence are signals of active brand equity management that justify the 18.5x forward multiple, not table stakes

→ vs conservative: Conservative analyst's bear case of 6 percent maximum drawdown is optimistic; genuine negative scenario could see 12 to 18 percent drawdown to $51.20 November 2025 low